ClinicalTrials.govpublic full text
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
dyskinesia, cerebral palsy, vesicular monoamine transporter 2 (vmat2) inhibitor, neurocrine, valbenazine, nbi-98854, dystonia, chorea, athetosis, athetoid cerebral palsy, choreoathetosis, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 854570
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.